Overview

Objective

The AB Emerging Markets Strategic Core Equities Fund - Active ETF (“EMSC ETF” or “Fund”) aims to achieve returns in excess of the MSCI Emerging Markets Index in Australian dollars, after fees, over the medium to long term. There is no guarantee that the Fund will achieve this objective or produce any positive returns.


Investment Strategy

The Fund is designed for equity investors who have a high risk and return profile and are seeking an investment in a portfolio comprising equity securities in the Investable Companies, which offer the potential for long-term capital growth with lower volatility than is typical for equity securities of emerging markets companies. The investor would typically have a five-year investment timeframe and be unlikely to need to withdraw money on less than one week’s notice. The investor would only seek to use the product for 25% or less of the total investable assets held by that investor as part of a more broadly diversified portfolio of assets. 

 

The Fund seeks to achieve its investment return objective by investing in a portfolio comprising equity securities in the Investable Companies.

 

The Fund will principally be comprised of equity securities of companies considered by the Investment Manager that are high quality, have low volatility and reasonable valuations and offer attractive shareholder returns. 

 

As at the date of the PDS, the Investment Manager does not intend to hedge foreign currency exposure arising from its equity investments into Australian dollars. However, the Investment Manager retains discretion to hedge foreign currency exposure at any time (including through the use of derivatives) and subsequently increase, decrease or eliminate such exposure. For example, the Fund may hedge all or part of its currency exposure to Australian dollars or provide currency exposures greater than that provided by the underlying equity exposure.

 

The Fund may also invest in financial products, including but not limited to common and preferred stocks (including American Depository Receipts and Global Depository Receipts), currency spot and forward contracts, stock index futures, exchange traded funds (ETFs), warrants, rights, private placements, including new issues and secondary offerings, securities convertible into common stock and Real Estate Investment Trusts (REITs).

 

Derivatives may be used to hedge foreign currency risks. Exchange-traded derivatives may be used on a temporary basis to more efficiently gain an economic exposure to the underlying assets (such as investing cash, managing volatility and gaining or reducing investment exposures). Other than for these temporary uses, the aggregate notional exposure of exchange-traded derivatives will, except in exceptional circumstances, be limited to 10% of the net asset value of the EMSC ETF. The assets of the EMSC ETF may be used as security (collateral) for derivatives entered into on behalf of the EMSC ETF. Derivatives will not be used for leverage or gearing purposes or to achieve a synthetic exposure to equities outside of the investment universe.

 

Key Facts

Inception Date

8 November 2025

Cboe Ticker

MORE

EMSC ETF (31 July 2026)

$5,078,279

Management Cost

1.00% p.a.

APIR Code

ACM0749AU

 

MUFG Corporate Markets

Investors in the EMSC ETF can:

  • Change your contact details
  • Update your bank details
  • Change your DRP election
 
 

Meet the Team


Portfolio Details

 

Domicile: Australia
Base Currency: Australian Dollars
Application/Redemption: Daily

Ratings

 
 

Access

Invest Through Cboe

You can invest in the EMSC ETF directly via your online broking account. The EMSC ETF is available through Cboe.

Invest Directly With the Fund

The EMSC ETF is also offered on a number of industry leading platforms. By downloading and completing the application form, investors can also buy units directly from AB provided they apply for the minimum investment of A$50,000 in units.

Investors should read the Product Disclosure Statement (PDS) and speak to their financial adviser before making a decision.

Speak to Your Financial Adviser

Before making a decision to invest, investors should speak with their financial adviser to see if the EMSC ETF is right for them.

 

Platform Availability

 
 

Fund Literature

 

Disclosure & Notices

 
 

AllianceBernstein Investment Management Australia Limited (ABN 58 007 212 606, AFSL 230 683) (“ABIMAL”) is the responsible entity of the AB Emerging Markets Strategic Core Equities Fund - Active ETF (ARSN 690 408 783) (“Fund”) and is the issuer of units in the Fund. ABIMAL has appointed AllianceBernstein Australia Limited (ABN 53 095 022 718, AFSL 230 698) (“ABAL”) as the investment manager of the Fund. ABAL in turn has delegated a portion of the investment manager function to AllianceBernstein L.P. The Fund’s Product Disclosure Statement (“PDS”) is available online or by contacting the client services team at ABAL at (02) 9255 1299. Investors should consider the PDS in deciding to acquire, or continue to hold, units in the Fund.

A Target Market Determination (“TMD”) for the Fund is available from our website. The TMD sets out the class of persons who comprise the target market for the Fund and the distribution conditions that are applicable, together with a number of other matters which should be considered by retail investors and their advisers.

Information, forecasts and opinions ("Information") set out on this website are not personal advice and have not been prepared for any recipient’s specific investment objectives, financial situation or particular needs. Neither the website nor the Information contained in it is intended to take the place of professional advice. Please note that past performance is not indicative of future performance, and projections, although based on current Information, may not be realised. Information can change without notice, and neither ABIMAL or ABAL guarantees the accuracy of the Information at any particular time. Although care has been exercised in compiling the Information contained on this website, neither ABIMAL or ABAL warrants that this document is free from errors, inaccuracies or omissions.

This document is released by ABAL.

The rating published on April 2026 for AB Emerging Markets Strategic Core Equities Fund - Active ETF is issued by Lonsec Research Pty Ltd ABN 11 151 658 561 AFSL 421 445 (Lonsec Research) for use in Australia only. Ratings are general advice only and have been prepared without taking account of investors’ objectives, financial situation or needs. Consider your personal circumstances, read the product disclosure statement and seek independent financial advice before investing. The rating is not a recommendation to purchase, sell or hold any product. Past performance information is not indicative of future performance. Ratings are subject to change without notice and Lonsec Research assumes no obligation to update. Lonsec Research uses objective criteria and receives a fee from the Fund Manager. Visit lonsec.com.au for ratings information and to access the full report. © 2026 Lonsec. All rights reserved.

The Zenith Investment Partners (ABN 27 103 132 672, AFS Licence 226872) (“Zenith”) rating (CXA:MORE and ACM0749AU assigned August 2026) referred to in this piece is limited to “General Advice” (s766B Corporations Act 2001) for Wholesale clients only.  This advice has been prepared without taking into account the objectives, financial situation or needs of any individual, including target markets of financial products, where applicable, and is subject to change at any time without prior notice.  It is not a specific recommendation to purchase, sell or hold the relevant product(s).  Investors should seek independent financial advice before making an investment decision and should consider the appropriateness of this advice in light of their own objectives, financial situation and needs.  Investors should obtain a copy of, and consider the PDS or offer document before making any decision and refer to the full Zenith Product Assessment available on the Zenith website.  Past performance is not an indication of future performance. Zenith usually charges the product issuer, fund manager or related party to conduct Product Assessments.  Full details regarding Zenith’s methodology, ratings definitions and regulatory compliance are available on our Product Assessments and at Fund Research Regulatory Guidelines.”

 
 

Looking for More Information?

Feel free to get in touch with our team, and we will get back to
you as soon as possible.